GE Healthcare has appointed Kieran Murphy as president and CEO. He succeeds John Flannery, who has been appointed CEO and chairman elect of GE. Murphy was appointed CEO of GE Healthcare Life Sciences in September 2011, and he joined GE Healthcare in 2008 from Whatman. He has also held leadership roles at Mallinckrodt, Novartis, Adprotech, ML Laboratories, and Innovata.
Robert Green, Natasha Frank
Veritas Genetics has appointed Robert Green and Natasha Frank to its medical and scientific advisory board. Green directs the Genomes2People research program. He also leads the first randomized trials to explore the implementation of medical sequencing in adults and newborns through the MedSeq and BabySeq projects. Frank leads research programs funded by the US National Institutes of Health, Veterans Administration, and the Department of Defense that investigate the biology of stem cells residing in human tissues and their relationship to genetic disease and cancer.
Molecular Assemblies has appointed Sean Freeman to its board of directors. Freeman currently serves as head of strategy and corporate development at NuVasive. He previously served as senior VP of business development for Cole-Parmer Instrument, and as head of corporate ventures and M&A at Life Technologies, which was later acquired by Thermo Fisher Scientific. He has also worked as an investment banker in Merrill Lynch's mergers & acquisitions group.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.